Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Avanos Medical stock last closed at $15.77, down 0.38% from the previous day, and has decreased 17.56% in one year. It has underperformed other stocks in the Medical Devices industry by 0.09 percentage points. Avanos Medical stock is currently +5.27% from its 52-week low of $14.98, and -37.82% from its 52-week high of $25.36.
As of Jan 15, 2025, there are 45.96M AVNS shares outstanding. The market capitalization of AVNS is $724.74M. In the past 24 hours, 383,894 AVNS shares were traded.
How to Buy Avanos Medical Stock
Wondering how to invest in Avanos Medical stock? Here's how.
Choose where to buy Avanos Medical stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you figure out where to buy Avanos Medical stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Choose your payment method and add your information.
Analyze Avanos Medical stock: The Avanos Medical ticker symbol is AVNS. Is Avanos Medical stock a good investment? Should you buy shares of AVNS? How do AVNS's underlying business fundamentals look? Do top analysts think Avanos Medical is a good buy? Why has AVNS's stock price moved recently? (Hint: Our stock research website can help you evaluate if AVNS is a good stock to buy).
Make your AVNS trade: Decide if you will purchase AVNS shares at the current market price or use a limit order to purchase AVNS stock at a particular price.
Get notifications regarding your investment in AVNS: Create a watchlist to get the latest news on your investment in Avanos Medical stock.
Step 1: Choose where to buy Avanos Medical stock
You will need an online brokerage account to access the NYSE market and buy AVNS stock.
A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global markets: From Technology to Financial Services, New York to Tokyo — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've picked your brokerage, you need to fill out some personal details so you can buy AVNS today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Avanos Medical stock
Once you have decided on the best place to buy Avanos Medical stock, it's absolutely critical to analyze their stock prior to buying, so you can wrap your head around the risk as well as the upside.
Avanos Medical shares at a glance
AVNS Price
$15.77
1w %
2.4%
1y %
-17.56%
5y %
-51.61%
P/E
45.06x
P/B
0.59x
P/S
1.06x
PEG
0.36x
Revenue
$681.50M
Earnings
$15.70M
Fore. Rev. Growth
5.28%
Fore. Earn. Growth
137.42%
Market Cap
$724.74M
Next Earnings
Feb 18, 2025
Next Dividend
N/A
Avanos Medical Overview
WallStreetZen was designed to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
Last year, AVNS earnings were $15.70M. Over the last four year, AVNS's earnings have gone up by 3.93% per year. This was slower than the Medical Devices industry average of 15.28%.
Last year, AVNS revenue was $681.50M. Over the past five year, AVNS's revenue has increased by 0.11% per year. This was slower than the Medical Devices industry average of 10.28%.
No, Avanos Medical doesn't provide an income stream by paying out dividends.
AVNS Social Trading Data
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your AVNS trade
You have two main order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are generally the best for newer investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to be certain you're buying or selling at a given price limit, use a limit order.
Click the Open Trade button and your broker will execute your order.
If you need more info about buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Avanos Medical share?
As of Jan 15, 2025, it costs $15.77 to buy one share of Avanos Medical stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $7, you can buy 0.444 shares of AVNS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.